Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ITGR vs EHC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHC Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

EHC Overall Winner 6-Pillar Tally: ITGR 1 – 5 EHC Matrix Metrics: ITGR 4 – 6 EHC

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Integer Holdings Corporation (ITGR) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ITGR carries a Unified Composite Score of 65.5/100 (BUY) at $126.97 (18.5x Forward P/E, 9.8% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin).

  • Composite vs. Pillar Nuance: While ITGR currently prints a higher short-term Unified Composite Score (65.5/100 BUY vs. EHC 52.0/100 HOLD), EHC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (18.4% vs. 9.8% operating margin) and revenue trajectory (+8.9% vs. -3.9% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ITGR vs EHC
ITGR NYSE
Integer Holdings Corporation
Electromedical & Electrotherapeutic Apparatus
$126.97
+0.21% 1D
Market Cap $4.3B
TTM Revenue $1.83B
Forward P/E 18.5x
Beta / 30D Vol 0.53β · 2% Vol
Unified Composite Score
65.5 / 100 BUY
Tech 59.0 Fund 59.0 Flow 60.0 Mom 58.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 63
RSI-14: 63.2 · SMA20: $126.62 · SMA50: $126.47
EHC NYSE Head-to-Head Winner
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15

6-Pillar Scorecard Institutional Category Breakdown (ITGR 1 – 5 EHC)

Columns: Metric · ITGR · EHC
1. Valuation Multiples EHC
Forward P/E 18.5x 19.4x
Trailing P/E 42.5x 21.2x
PEG Ratio 3.06x 0.41x
EV / Revenue 3.1x 2.5x
2. Growth & Scale EHC
Revenue Growth (YoY) -3.9% +8.9%
Earnings Growth (YoY) -61.3% +21.6%
TTM Revenue (USD) $1.83B $6.34B
Market Cap $4.3B $13.0B
3. Profitability & Quality EHC
Gross Margin 25.1% 44.1%
Operating Margin 9.8% 18.4%
Net Profit Margin 5.7% 10.2%
Return on Equity (ROE) 6.0% 25.1%
4. Balance Sheet & Cash Flow EHC
Cash Generation (TTM) $83M $457M
Cash Flow Margin 4.5% 7.2%
Net Cash / Leverage $1.33B Net Debt (0.78x D/E) $2.73B Net Debt (1.05x D/E)
Dividend Yield None (0.00%) 0.58%
5. Options & Positioning ITGR
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 0.7% (<1st %ile) 27.0% (8th %ile)
Put/Call OI Skew 0.01x (Call-Skewed) 0.25x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat EHC
OpEx & R&D Intensity 15.3% of Rev ($279M) 25.7% of Rev ($1.63B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Medical Devices Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ITGR (4) vs EHC (6)
Institutional Metric ITGR EHC Criterion Row Edge
Market Capitalization
Scale
$4.3B $13.0B Larger Scale EHC
Trailing P/E Ratio
Valuation
42.5x 21.2x Lower Multiple EHC
Forward P/E Ratio
Valuation
18.5x 19.4x Lower Multiple ITGR
Revenue Growth (YoY)
Growth
-3.9% +8.9% Higher Growth EHC
Operating Margin (TTM)
Profitability
9.8% 18.4% Higher Margin EHC
Net Profit Margin
Profitability
5.7% 10.2% Higher Margin EHC
Return on Equity (ROE)
Capital Efficiency
6.0% 25.1% Higher ROE EHC
52-Week Range Position
Momentum
91% ($67–$133) 80% ($93–$144) Stronger Trend ITGR
Beta / 30D Volatility
Risk Regime
0.53β · 2% Vol -0.10β · 40% Vol Lower Realized Risk ITGR
Unified Institutional Score
Composite Signal
65.5 / 100 (BUY) 52.0 / 100 (HOLD) Higher Composite ITGR
Trailing 12M Revenue (USD)
Operating Scale
$1.83B $6.34B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
25.1% 44.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.06x PEG · 3.1x EV/Rev 0.41x PEG · 2.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$83M ($1.33B Net Debt (0.78x D/E)) $457M ($2.73B Net Debt (1.05x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +10.93 pp
ITGR: +0.21% · EHC: +11.14%
3M Horizon EHC +14.89 pp
ITGR: +1.5% · EHC: +16.39%
6M Horizon ITGR +7.18 pp
ITGR: +41.12% · EHC: +33.94%
1Y Horizon ITGR +60.69 pp
ITGR: +87.66% · EHC: +26.97%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ITGR Revenue EHC Revenue ITGR Op. Margin EHC Op. Margin Margin Leader
FY2018 $1.22B $4.28B 12.8% 13.0% EHC
FY2019 $1.26B $4.61B 12.5% 13.3% EHC
FY2020 $1.07B $3.57B 11.2% 15.8% EHC
FY2021 $1.22B $4.01B 11.1% 13.9% EHC
FY2022 $1.33B $4.35B 8.5% 12.4% EHC
FY2023 $1.56B $4.80B 10.5% 7.3% ITGR
FY2024 $1.72B $5.37B 12.1% 8.5% ITGR
FY2025 $1.85B $5.94B 11.9% 9.5% ITGR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ITGR CONSOLIDATION
71d in phase · OBV NEUTRAL
Current IV 0.7%
IV Percentile <1st %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ITGR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ITGR Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $4.3B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 15.3% of Rev ($279M)
90D Engineering Disclosures 0 Published
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published

Investor FAQ ITGR vs EHC Key Questions & Quantitative Answers

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Integer Holdings Corporation (ITGR) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ITGR carries a Unified Composite Score of 65.5/100 (BUY) at $126.97 (18.5x Forward P/E, 9.8% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin). Composite vs. Pillar Nuance: While ITGR currently prints a higher short-term Unified Composite Score (65.5/100 BUY vs. EHC 52.0/100 HOLD), EHC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (18.4% vs. 9.8% operating margin) and revenue trajectory (+8.9% vs. -3.9% YoY).

EHC leads the Growth & Scale pillar: ITGR posts -3.9% YoY revenue growth and -61.3% YoY earnings growth on $1.83B TTM revenue (25.1% gross margin, 9.8% operating margin), compared with EHC at +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ITGR cumulative revenue shifted +51.6% while EHC shifted +38.8%. In operating R&D and SG&A reinvestment, ITGR deploys 15.3% of Rev ($279M) (0 90-day corporate R&D disclosures) versus 25.7% of Rev ($1.63B) (0 disclosures) for EHC.

EHC screens cheaper on headline valuation multiples. ITGR trades at 18.5x Forward P/E, 42.5x Trailing P/E, 3.06x PEG, and 3.1x EV/Revenue (4.5% FCF margin), whereas EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ITGR (6.0% ROE) versus EHC (25.1% ROE) capital efficiency.

In options market volatility and institutional positioning, ITGR carries 0.7% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.53β · 2% Vol realized risk). By comparison, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.